Conquering Diseases

Study Of An Investigational Drug For Multiple Sclerosis

Description

Seeking adult men and women with multiple sclerosis for a study of an investigational drug that has not yet been tested in people.

Overview

Following a screening period of up to 4 weeks, participants in this study will get an infusion of the investigational drug and may need to stay in the clinic for up to 3 days. There will be 10 short follow-up visits.

What we're hoping for

We are studying how well an investigational drug for multiple sclerosis is tolerated at increasing doses.

Additional Information

ClinicalTrials.gov Identifier: Not Available

 Principal Investigator

Carolina  Ionete, MD

UMass Memorial Health Care

 Study Contact

Nimmy  Nimmy KanichaiFrancis

nimmy.kanichaifrancis@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989